By Marie Rosenthal and David Bronstein
“Uncertain” might be one word to describe 2017.
Health-system pharmacists had to grapple with repeated attempts to repeal the Affordable Care Act (ACA); attacks on the federal 340B Drug Pricing Program; rising drug prices and critical drug shortages; the moving target of U.S. Pharmacopeial Convention (USP) Chapter <800> preparation; and for some, catastrophic storms and flooding. Those were just a handful of challenges that pharmacists